Delivery Order SPE2DB22D2206-SPE2DB24FJQ02

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $4,104.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 25, 2024. The contract is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical product, with an ultimate completion date of October 28, 2024. This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,071.66, is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a medical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML. The contract has a ceiling value of $2,562.65 and an ultimate completion date of November 8, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, with a ceiling value of $1,556.48. The contract is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a medical supply used in healthcare settings. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
This is a $2,161.86 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical commodity, to support military healthcare programs. The contract has an ultimate completion date of April 30, 2024 and is a firm fixed-price contract. This award is associated with a larger $999,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML. The contract has a ceiling value of $1,689.48 and an ultimate completion date of August 13, 2024. Amerisourcebergen has been awarded this delivery order as part of its Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award, valued at $3,156.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical product. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $2,194.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of DIPRIVAN 200 MG/20 ML VIAL 20ML, a pharmaceutical product. The award has an ultimate completion date of August 12, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at up to $999,999,999...
The Defense Logistics Agency (DLA) awarded a $2,656.26 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4,564,339,067 units of the pharmaceutical product DIPRIVAN 1,000 MG/100 ML VIAL 100ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,143.73, is a delivery order for the pharmaceutical product DIPRIVAN 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of October 26, 2023 and a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJQ02
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML. The contract has a ceiling value of $12,297.32 and is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by August 6, 2024.

Generated 11/4/24, 10:53 AM